Table 3.
Compound (6M0J) | Mode of Action | Hydrophobic | Polar | Hydrogen bonding | п-п stacking | Charged |
---|---|---|---|---|---|---|
Farnesyl transferase inhibitor | Val93, Leu29, Ala387, Pro389, Phe390 | His33, Gln96, Thr92, Gln388 | Thr92 | Lys26, Asp30, Glu37, Arg393 | ||
Anti-HIV Protease inhibitor | Chain A: Phe390, Pro389, Ala387, Ala386, Val93, Leu29 Chain E: Tyr505, Ile418, Gly416 |
Chain A: Gln388, Asn33, Gln96, Thr92, Gln E: 409 | Chain A: Gln96, Chain E: Lys417, Gln409, Gln406, Arg403 | Chain E Arg403, | Chain A: Glu37, Arg393, Asp30, Lys26 Chain E: Glu406, Asp405, Arg403, Arg408, Lys417 |
|
Tyrosine Kinase inhibitor; Epidermal Growth Factor Receptor (EGFR) inhibitor | Chain A: Ala387, Ala386, Leu29, Val93, Pro389 Chain E: Tyr495, Gln496, Tyr453 |
Chain A: His33, Gln388, Gln96 Chain E: Gln 493, Ser494 | Chain E: Tyr 453, Arg403, | Chain A: Glu37, Asp38, Asp30, Lys353, Lys26, Arg393 Chain E: Arg403, |
||
Bruton Tyrosine Kinase Inhibitor | Chain A: Pro389, Ala 387, Ala386, Met383, Gly354, Phe356 Chain E: Tyr505, Gly504, Val503, Gly502 |
Chain A: Asn33, Gln388, Thr324 | Chain E: Gly504, Arg403, Asp405 | Chain E: Tyr505 | Chain A: Glu37, Arg393 Chain E: Asp405, Arg408, Arg403, |
|
Lipoprotein associated phospholipase (A2) Lp-plA2 Inhibitor | Chain A: Pro389, Ala387, Phe390, Ala386, Leu29, Val93 Chain E: Tyr505, Leu455, Gly504 |
Asn33, Gln388, Thr92, Gln96 | Chain A: Asp30 | Chain E: Arg403 | Chain A: Asp30, Lys26, Arg393 Chain E: Lys417, Arg408, Arg403 |
|
Synthetic Antimalarial Drug | Chain A: Pro389, Ala387, Ala386, Val93, Leu 29 Chain E: Tyr505 |
Chain A: Asn33, Gln388, Thr92, Gln96 | Chain A: Asn33, Gln96, Arg393, Glu37 Chain E: Tyr505, Arg403 |
Chain A: Arg393, Asn33 | Chain A: Lys26, Asp30, Glu37, Arg393, Chain E: Arg403, Asp405 | |
Antimalarial Drug Anti-arthritis |
Chain E: Tyr453, Tyr495, Gln496, Phe497, Tyr505 Chain A: Phe390, Pro389, Ala387, Ala386 |
Chain E: Ser494, Gln493 | Chain A: Lys353, Chain E: Asp405 | Chain E: Arg403 | Chain A: Asp38, Glu37, Arg393, Lys353, Chain E: Arg403, Asp405, Glu406 | |
Antimalarial Drug | Chain A: Leu29, Val93, Phe390, Pro389, Ala387, Ala386 Chain E: Gly504, Tyr505 |
Chain A: Asn33, Gln96 | Chain E: Asp405 | Chain A: Lys26, Arg393, Asp30, Glu37 Chain E: Arg403 |
||
Anti-HIV Inhibitor | Chain A: Pro389, Ala387, Ala386, Met383, Phe356, Gly354 Chain E: Tyr505, Gly504, Val503, Gly502, Ile418, Gly416 |
Chain A: Asn33, Gln388, Thr324 Chain E: Gln409 |
Chain E: Asp405, Arg403, Lys417, Gln409 | Chain E: Asp405, | Chain E: Lys417, Arg408, Arg403 Chain A: Arg393 |
|
Potent Irreversible EFGR receptor | Chain A: Leu29, Val93, Phe390, Pro389, Ala387, Ala386 Chain E: Tyr505, Tyr495, Gly496, Tyr453 |
Chain A: Asn33, Gln96, Gln388 Chain E: Ser494, Gln493 | Chain E: Arg403, Tyr453 Chain A: Asn33 |
Chain A: Asp30, Lys26, Arg393, Lys353, Glu37, Asp38 Chain E: Arg403 |
||
Anti-HIV Inhibitor | Chain A: Pro389, Ala387, Phe390 Chain E: Tyr505 |
Chain A: Asn33, Gln388, Gln96 Chain E: Gln409 |
Chain A: Asp30, Glu37 Chain E: Arg403 |
Chain E: Arg408 | Chain A: Asp30, Glu37, Arg393 Chain E: Lys417, Arg408, Arg403, Asp405, Glu406 |
|
Antiviral Drug |
Chain A: Pro389, Phe390 Chain E: Tyr505, Tyr495, Gly496, Tyr453, Ile418, Gly416 |
Chain A: Asn33, Chain E: Ser494, Gln493, Gln409, Tyr415 | Chain A: Asp30 Chain E: Glu406, Gln409, Tyr505, Arg403 |
Chain A: Asp30, Glu37, Glu35, Asp38 Arg393, Lys353 Chain E: Lys417, Arg403, Asp405, Glu406 |